Evidence map›Paper›PMID 7685906›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1993

Cloning and expression of GRK5: a member of the G protein-coupled receptor kinase family.

P Kunapuli, J L Benovic

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 159 citations in OpenAlex.

  1. Review
  2. Article
  3. Role of G protein-coupled receptor kinases (GRKs) in βPharmacology research & perspectives · 2024
    Article
  4. Review
  5. Review
  6. Review
  7. Targeting GRK5 for Treating Chronic Degenerative Diseases.International journal of molecular sciences · 2021
    Review
  8. Targeting G protein-coupled receptor kinases (GRKs) to G protein-coupled receptors.Current opinion in endocrine and metabolic research · 2021
    Article
  9. Article
  10. Article
  11. A Brief History of the β-Arrestins.Methods in molecular biology (Clifton, N.J.) · 2019
    Review
  12. Review
  13. Article
  14. Review
  15. Proinflammatory Cytokines Mediate GPCR Dysfunction.Journal of cardiovascular pharmacology · 2017
    Review
  16. Review
  17. Review
  18. Article
  19. "Canonical and non-canonical actions of GRK5 in the heart".Journal of molecular and cellular cardiology · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

P KunapuliDepartment of Pharmacology, Jefferson Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107.
J L Benovic
Jefferson Institute · USThomas Jefferson University · US

Funding

G PROTEIN-COUPLED RECEPTOR KINASESR01GM044944 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI BENOVIC, JEFFREY L · 1990 to 2016
$5.3M
NIGMS NIH HHS GM44944
6 · The paper itself

Abstract

Guanine nucleotide binding protein (G-protein)-coupled receptor kinases (GRKs) specifically phosphorylate the agonist-occupied form of G-protein-coupled receptors such as the beta 2-adrenergic receptor and rhodopsin. The best characterized members of this family include the beta-adrenergic receptor kinase (beta ARK) and rhodopsin kinase. To identify additional members of the GRK family, the polymerase chain reaction was used to amplify human heart cDNA using degenerate oligonucleotide primers from highly conserved regions unique to the GRK family. Here we report the isolation of a cDNA that encodes a 590-amino acid protein kinase, termed GRK5, which has 34.8% and 47.2% amino acid identities with beta ARK and rhodopsin kinase, respectively. Interestingly, GRK5 has an even higher homology with Drosophila GPRK-2 (71.0% identity) and the recently identified human IT11 (69.1% identity). Northern blot analysis of GRK5 with selected human tissues reveals a message of approximately 3 kilobases with highest levels in heart, placenta, lung > skeletal muscle > brain, liver, pancreas > kidney. GRK5, overexpressed in Sf9 insect cells using the baculovirus system, was able to phosphorylate rhodopsin in a light-dependent manner. In addition, GRK5 neither contains a consensus sequence for isoprenylation like rhodopsin kinase nor is activated by G-protein beta gamma subunits like beta ARK1. Thus, GRK5 represents a member of the GRK family that likely has a unique physiological role.

Indexed as

Eye ProteinsGene ExpressionMultigene FamilyProtein Serine-Threonine KinasesAmino Acid SequenceAnimalsBase SequenceBlotting, NorthernCattleCell LineCloning, MolecularG-Protein-Coupled Receptor Kinase 1G-Protein-Coupled Receptor Kinase 5GTP-Binding ProteinsHumansMacromolecular SubstancesEye ProteinsG-Protein-Coupled Receptor Kinase 1G-Protein-Coupled Receptor Kinase 5GRK1 protein, humanGRK5 protein, humanGTP-Binding ProteinsMacromolecular SubstancesOligodeoxyribonucleotidesPoly AProtein KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesReceptors, Cell SurfaceRNARNA, Messenger

Identifiers

PMID7685906
PMCPMC46766
OpenAlexW2072842460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.